Pregnant WomenNCT07585916
Prenatal Yoga Intervention in Pregnant Women
A study testing Prenatal Yoga in people with Pregnant Women and Prenatal Yoga, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study is to determine the effects of a prenatal yoga intervention on traumatic childbirth perception, self-perception, and delivery preferences in pregnant women. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pregnant Women, Prenatal Yoga, Trauma
- What is being tested?
- Prenatal Yoga
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2026to 30 Dec 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being at or beyond the 16th week of gestation (second trimester or later)
- Being aged 18 years or older
- Having no diagnosis of high-risk pregnancy based on obstetric evaluation
- Having no medical restriction on physical activity or yoga practice as determined by a physician
- Providing written informed consent after being informed about the study
Who cannot join
- Diagnosis of high-risk pregnancy (e.g., preeclampsia, placenta previa, premature rupture of membranes, risk of preterm birth, or other serious obstetric complications)
- Physician-imposed restriction on physical activity
- Presence of serious systemic conditions that would prevent participation in yoga practice
- Inability to complete the questionnaires reliably due to psychiatric or cognitive conditions
- Declining to participate or not providing informed consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Bartın University
Bartın, Bartın, 74100
Duygu Özer, Asst. prof, +9 05061291978, duyguozer2016@hotmail.com
About this study
Official title: Effects of a Prenatal Yoga Intervention on Traumatic Childbirth Perception, Self-Perception, and Delivery Preferences in Pregnant Women
The aim of this study is to determine the effects of a prenatal yoga intervention on traumatic childbirth perception, self-perception, and delivery preferences in pregnant women.
Read the detailed description
This study will be conducted with voluntary pregnant women aged 18 years and older, at or beyond the 16th week of gestation, and without a diagnosis of high-risk pregnancy. Participants will be randomly assigned to the intervention and control groups using a computer-generated simple randomization method (https://www.random.org/integers/
) to ensure unbiased allocation. The intervention group will consist of 8-12 participants per group, and the program will be implemented in three separate groups. Participants in the intervention group will receive a prenatal yoga program consisting of eight sessions delivered twice weekly, while the control group will receive routine prenatal care without any additional intervention from the researchers. Data collection instruments will be administered at baseline (pre-test), at the end of the eighth session (post-test), and at a one-month follow-up.
- Conditions
- Pregnant Women, Prenatal Yoga, Trauma, Body Image, Delivery
- Being tested
- Prenatal Yoga
- Keywords
- perception of traumatic childbirth, body image, preferred mode of delivery, pregnant women, prenatal yoga
- Medical subject headings
- Wounds and Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Prenatal YogaBehavioural
Participants in the intervention group received a structured prenatal yoga program consisting of eight sessions delivered twice weekly. Each session lasted approximately 45 minutes and was conducted in accordance with safe prenatal exercise guidelines.
| Study group | Role | What they receive |
|---|---|---|
| Experimental | Experimental | Prenatal Yoga Program was applied to the intervention group. Receives: Behavioral: Prenatal Yoga |
| Control | No intervention | Participants in the control group received routine prenatal care only and were not exposed to any structured intervention during the study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Traumatic Childbirth Perception Scale
The Traumatic Childbirth Perception Scale is a self-report instrument designed to assess perceptions of traumatic childbirth, including physical, emotional, and psychological aspects. The scale consists of 13 items. Each item is rated on a scale ranging from 0 to 10, and total scores range from 0 to 130, with higher scores indicating higher levels of perceived traumatic childbirth. Mean total scores are used to interpret the level of traumatic childbirth perception. The score ranges are categorized as follows: 0-26 (very low), 27-52 (low), 53-78 (moderate), 79-104 (high), and 105-130 (very high).
Measured: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
Secondary outcomes (2)
Pregnant Women's Self-Perception Scale
The scale consists of 12 items rated on a 4-point Likert scale ranging from 1 (never) to 4 (always). It comprises two subscales: maternal perception related to pregnancy (7 items) and body perception during pregnancy (5 items). Higher scores on the maternal perception subscale (range: 7-28) indicate higher levels of positive maternal perception. In contrast, higher scores on the body perception subscale (range: 5-20) reflect more negative body perception during pregnancy.
Measured: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
Preferred Mode of Delivery Scale for Pregnant Women
The scale is suitable for women without systemic or psychiatric disorders and who conceived naturally. It consists of 18 items and three subscales: self-efficacy, normative beliefs, and preferences. Items are rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Items 6-14 and 16-18 are reverse scored. The total score is calculated by summing all item responses, and subscale scores can be obtained by summing the corresponding items. The scale does not have a cut-off point. Total scores range from 18 to 90, with higher scores indicating a stronger preference for vaginal delivery, as all items are scored in favor of vaginal birth for ease of interpretation.
Measured: Baseline, immediately after the 8-week intervention, and 1 month post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 May 2026
- Study start15 May 2026 (estimated)
- Primary completion30 Sep 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pregnant WomenStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Intervention and control group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 46 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Duygu Özer, PhD, Bartın Unıversity
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07585916
- Sponsor's protocol ID
- BARU-SBF-DO-4
- Status last verified
- May 2026
- First submitted
- 2 May 2026
- Last updated
- 14 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No